Masaki Tosa
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masaki Tosa.
Scandinavian Journal of Gastroenterology | 2006
Masaki Tosa; Kenichi Negoro; Yoshitaka Kinouchi; Hiroko Abe; Eiki Nomura; Sho Takagi; Hiroyuki Aihara; Shinya Oomori; Mikako Sugimura; Kazuma Takahashi; Nobuo Hiwatashi; Seiichi Takahashi; Tooru Shimosegawa
Objective. Population-specific differences in the genetic susceptibility to inflammatory bowel disease (IBD) are indicated by the fact that Crohns disease (CD) in Japanese patients does not have any of the common CARD15 variants that are associated with CD in Caucasians. Recently, the disease-causing mutation in the IBD5 haplotype was identified. The TC haplotype, composed of L503F in SLC22A4 and −207G/C in SLC22A5 promoters, was reported to alter the function of the organic cation transporter and to be associated with CD in Caucasians. To determine whether the TC haplotype is also associated with IBD in a Japanese population, we genotyped L503F and −207G/C variants in Japanese subjects. Furthermore, we also performed a case-control association study with all representative single nucleotide polymorphisms (SNPs) in IBD5 using previous information of linkage disequilibrium extension reported in Japanese patients to determine whether there were variants in IBD5 specifically associated with IBD in Japanese patients. Material and methods. A total of 758 Japanese individuals, 241 patients with CD, 247 patients with ulcerative colitis (UC) and 270 healthy controls, were analyzed in this study. Genotyping for SNPs was determined by polymerase chain reaction-restriction fragment length polymorphism analysis. Results. We found L503F and −207G/C to be very rare (<1% frequency) in CD, UC and HC in the Japanese population. Furthermore, we also found that none of the representative SNPs in IBD5 was associated with CD or UC in the Japanese subjects. Conclusions. In contrast to Caucasians, IBD5 is not a major component of the susceptibility to IBD in the Japanese population.
Tissue Antigens | 2009
Hiroki Aizawa; Yoshitaka Kinouchi; Kenichi Negoro; Eiki Nomura; Go Imai; S. Takahashi; Sho Takagi; Yoichi Kakuta; Masaki Tosa; A. Mochida; Yoshifumi Matsumura; Katsuya Endo; Tooru Shimosegawa
Recently, a genome-wide association study for ulcerative colitis (UC) in the UK population was reported, and several susceptibility loci including the human leukocyte antigen (HLA) region were identified. The strongest association in the HLA region was found at a 400 kb haplotype block containing HLA-DRB1. In Japanese population, previous study suggested the association between UC and HLA-B*52; however, HLA typing was determined using serotyping with the small sample size. The purpose of this study was to perform an association study in HLA-B by genotyping. A total of 320 patients with UC and 322 healthy controls were recruited in this case-control study. All subjects were Japanese. Genotyping of HLA-B was performed by polymerase chain reaction using a sequence-specific primer. When the allele frequencies were compared, significant associations were found with B*52 [odds ratio (OR) = 3.65, P = 1.6 x 10(-17), P(c) = 3.7 x 10(-16)] and B*4002 (OR = 0.52, P = 0.00030, P(c) = 0.0068). The allele frequency of B*52 was significantly higher in patients diagnosed before 40 years of age than in those diagnosed after 40 years (OR = 1.79, P = 0.010, P(c) = 0.020). A combination association map of Japanese UC using our current and previous studies showed two equal peaks of association on HLA-DRB1 and HLA-B, indicating the possible existence of two casual variants in the HLA region inside and outside the 400 kb block found in UK. We conclude that HLA-B contributes to the susceptibility to Japanese UC, especially cases with younger age of onset. The strength of association for HLA-B was equal to that for HLA-DRB1 in Japanese UC, in contrast to the UK population.
Tissue Antigens | 2007
A. Mochida; Yoshitaka Kinouchi; Kenichi Negoro; S. Takahashi; Sho Takagi; Eiki Nomura; Yoichi Kakuta; Masaki Tosa; Tooru Shimosegawa
Carcinogenesis | 2006
Yuichirou Sato; Seiichi Takahashi; Yoshitaka Kinouchi; Manabu Shiraki; Katsuya Endo; Yoshifumi Matsumura; Yoichi Kakuta; Masaki Tosa; Atsuhiro Motida; Hiroko Abe; Go Imai; Hiroshi Yokoyama; Eiki Nomura; Kenichi Negoro; Sho Takagi; Hiroyuki Aihara; Ken-ichi Masumura; Takehiko Nohmi; Tooru Shimosegawa
Suizo | 2010
Tetsuya Yamagiwa; Shinichi Ikeya; Masao Kusano; Masaki Tosa; Norihiro Shimada; Naohiro Dairaku; Toshiaki Ojima; Tatsuo Oriuchi; Haruo Nakayama; Nobuo Hiwatashi; Takeshi Aoki; Shigeyuki Asano
Pediatric Dermatology | 2018
Masao Kusano; Daisuke Komazawa; Masaki Tosa; Tomoyuki Ikeda; Seiichi Takahashi; Shinichi Ikeya; Haruo Nakayama
Pediatric Dermatology | 2017
Masao Kusano; Daisuke Komazawa; Hiromichi Ito; Masaki Tosa; Kaname Uno; Tomoyuki Ikeda; Seiichi Takahashi; Shinichi Ikeya; Haruo Nakayama
Pediatric Dermatology | 2017
Masao Kusano; Daisuke Komazawa; Hiromichi Ito; Masaki Tosa; Kaname Uno; Tomoyuki Ikeda; Seiichi Takahashi; Shinichi Ikeya; Haruo Nakayama
Pediatric Dermatology | 2017
Masao Kusano; Daisuke Komazawa; Hiromichi Ito; Masaki Tosa; Kaname Uno; Tomoyuki Ikeda; Seiichi Takahashi; Shinichi Ikeya; Haruo Nakayama
Pediatric Dermatology | 2016
Masao Kusano; Daisuke Komazawa; Hiromichi Ito; Masaki Tosa; Tomoyuki Ikeda; Seiichi Takahashi; Shinichi Ikeya; Haruo Nakayama; Nobuo Hiwatashi